Patent · US Active

Mutant transaminases as well as methods and uses relating thereto

US10017749B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Steven Paul Hanlon · Bottmingen, CH
Hans Iding · Rheinfelden (Baden), DE
Paul Spurr · Riehen, CH
Beat Wirz · Basel, CH
Uwe Bornscheuer · Greifswald, DE
Ioannis Pavlidis · Boulder, US
Martin Weiss · Greifswald, DE

Key dates

Filing date	Apr 15, 2016
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Apr 15, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y206/01
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to a mutant transaminase with increased transaminase activity relative to the wild-type transaminase, a fusion protein comprising the transaminase, a polynucleotide coding for the transaminase, a host cell comprising the polynucleotide, mutant transaminase and/or fusion protein, a method of producing an amine with the mutant transaminase or fusion protein and the use of the mutant transaminase or fusion protein for the production of an amine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.